THERMAL STUDY OF THE POLYETHYLENEGLYCOL 6000-TRIAMTERENE SYSTEM

被引:8
作者
GINES, JM
ARIAS, MJ
RABASCO, AM
SANCHEZSOTO, PJ
机构
[1] UNIV SEVILLA,INST CIENCIA MAT,CTR MIXTO,POB 1115,E-41080 SEVILLE,SPAIN
[2] UNIV SEVILLA,FAC FARM,DEPT FARM & TECNOL FARMACEUT,E-41012 SEVILLE,SPAIN
来源
JOURNAL OF THERMAL ANALYSIS | 1993年 / 40卷 / 02期
关键词
DSC; PHASE DIAGRAM; HOT STAGE MICROSCOPY; POLYETHYLENEGLYCOL 6000-TRIAMTERENE SYSTEM;
D O I
10.1007/BF02546614
中图分类号
O414.1 [热力学];
学科分类号
摘要
This paper examines binary polyethyleneglycol (molecular weight 6000)-Triamterene (PEG 6000-T) solid dispersions (5-40 w/w% of T) prepared by the fusion carrirer method, and physical mixtures (5-90 w/w% of T) are studied using DSC and Hot Stage Microscopy (HSM). The use of these combined techniques allows to explain the thermal behaviour on the basis of dissolution of T in the liquid carrier according to the progressive disappearance of the original crystals over a wide range of temperatures (ca. 100-degrees-C). The above fact, and possibly the sublimation of T, also could explain that at low T content (less-than-or-equal-to 30 w/w%), DSC curves exhibited only a single endothermic peak and/or weak endothermic peaks. On the basis of DSC data, a tentative phase diagram of this system is proposed.
引用
收藏
页码:453 / 462
页数:10
相关论文
共 10 条
[1]  
ARNAUD P, 1990, S T P PHARMA, V6, P48
[2]  
BEKERS O, 1991, DRUG DEV IND PHARM, V11, P1503
[3]   PHARMACEUTICAL APPLICATIONS OF SOLID DISPERSION SYSTEMS [J].
CHIOU, WL ;
RIEGELMAN, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (09) :1281-+
[4]   PHASE SOLUBILITY TECHNIQUE IN STUDYING FORMATION OF COMPLEX SALTS OF TRIAMTERENE [J].
DITTERT, LW ;
HIGUCHI, T ;
REESE, DR .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1964, 53 (11) :1325-&
[5]   PREFORMULATION STUDIES ON SOLID DISPERSIONS CONTAINING TRIAMTERENE OR TEMAZEPAM IN POLYETHYLENE GLYCOLS OR GELUCIRE 44 14 FOR LIQUID FILLING OF HARD GELATIN CAPSULES [J].
DORDUNOO, SK ;
FORD, JL ;
RUBINSTEIN, MH .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1991, 17 (12) :1685-1713
[6]  
FORD JL, 1986, PHARM ACTA HELV, V61, P69
[7]  
LEFEBVRE C, 1985, STP PHARM, V1, P300
[8]  
NAKAI Y, 1981, CHEM PHARM BULL, V101, P1016
[9]  
PRUITT AW, 1977, CLIN PHARMACOL THER, V21, P610
[10]  
RABASCO AM, 1990, 6TH S BIOPH PHARM BR, P27